Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4186 stock hub

TPEX/4186 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4186is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

967.5M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4186

In the news

Latest news · TPEX/4186

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E34.7

P25 14.4P50 18P75 31.9

ROE10.4

P25 -16.2P50 0.3P75 9.8

ROIC7.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4186 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

TWD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	165
Employees Change	11%
Employees Change Percent	7.14
Enterprise value	TWD 1.1B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004186002
Last refreshed	2026-05-10
Market cap	TWD 967.5M
Price	TWD 10.8
Price currency	TWD
Rev Per Employee	2,210,848.48x
Sector	Healthcare
Sic	2836
Symbol	tpex/4186
Website	https://www.biotest.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.9%
EV Earnings	38.89x
EV/EBIT	37.64x
EV/EBITDA	22.41x
EV/FCF	55.18x
EV/Sales	2.99x
FCF yield	2.04%
P/B ratio	3.39x
P/E ratio	34.68x
P/S ratio	2.65x
PE Ratio3 Y	52.83x
PE Ratio5 Y	81.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.94%
EBITDA Margin	13.34%
FCF margin	5.42%
Gross margin	64.16%
Gross Profit	TWD 234.1M
Gross Profit Growth	-6.86%
Gross Profit Growth Q	7.55%
Gross Profit Growth3 Y	0.71%
Gross Profit Growth5 Y	8.66%
Net Income	TWD 28M
Net Income Growth	22.61%
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Net Income Growth3 Y	9.43%
Pretax Margin	7.44%
Profit Margin	7.69%
Profit Per Employee	TWD 169,982
Profitable Years	2
ROA	2.55
Roa5y	-0.26
ROCE	6.11
ROE	10.36
Roe5y	-4.59
ROIC	7.1
Roic5y	-1.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.47%
Cagr1y	-22.87%
Cagr3y	-19.62%
Cagr5y	-14.03%
EPS Growth	24
EPS Growth Quarters	5
EPS Growth Years	2
EPS Growth3 Y	9.23
FCF Growth	352.74%
FCF Growth3 Y	-13.38%
OCF Growth	538.05%
OCF Growth3 Y	13.35%
Revenue Growth	3x
Revenue Growth Q	11.66x
Revenue Growth Years	2x
Revenue Growth3 Y	2.49x
Revenue Growth5 Y	5.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.51
Assets	TWD 746.7M
Cash	TWD 140.7M
Current Assets	TWD 237.5M
Current Liabilities	TWD 264.8M
Debt	TWD 264.1M
Debt EBITDA	TWD 5.43
Debt Equity	TWD 0.93
Debt FCF	TWD 13.36
Equity	TWD 285.1M
Interest Coverage	4.44
Liabilities	TWD 461.6M
Long Term Assets	TWD 509.2M
Long Term Liabilities	TWD 196.9M
Net Cash	TWD -123.4M
Net Cash By Market Cap	TWD -12.75
Net Debt EBITDA	TWD 2.53
Net Debt Equity	TWD 0.43
Net Debt FCF	TWD 6.24
Tangible Book Value	TWD 284.9M
Tangible Book Value Per Share	TWD 3.13
WACC	5.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.98
Inventory Turnover	6.46
Net Working Capital	TWD 52.2M
Quick ratio	0.88
Working Capital	TWD -5.5M
Working Capital Turnover	TWD -10.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-58.73%
1Y total return	-22.86%
200-day SMA	11.71
3Y total return	-48.08%
50-day SMA	10.68
50-day SMA vs 200-day SMA	50under200
5Y total return	-53.04%
All Time High	80
All Time High Change	-86.5%
All Time High Date	2012-11-27
All Time Low	9.51
All Time Low Change	13.56%
All Time Low Date	2026-04-08
ATR	0.73
Beta	0.45
Beta1y	0.97
Beta2y	0.42
Ch YTD	-3.14
High	11.05
High52	17.65
High52 Date	2025-09-11
High52ch	-38.81%
Low	10.45
Low52	9.51
Low52 Date	2026-04-08
Low52ch	13.57%
Ma50ch	1.15%
Price vs 200-day SMA	-7.75%
RSI	47.24
RSI Monthly	38.84
RSI Weekly	43.98
Sharpe ratio	-0.25x
Sortino ratio	-0.39
Total Return	1.12%
Tr YTD	-3.14
Tr1m	6.4%
Tr1w	-1.82%
Tr3m	-1.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 29M
Operating Income Growth	-33.4
Operating Income Growth3 Y	-1.38
Operating margin	7.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,034,467%
Net Borrowing	29,532,000
Shares Insiders	11.07%
Shares Out	90,000,000
Shares Qo Q	0%
Shares Yo Y	-1.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 19.8M
Average Volume	358,590.2x
Bv Per Share	3.13
CAPEX	TWD -33.4M
Ch10y	-59.41
Ch1m	6.4
Ch1w	-1.82
Ch1y	-22.86
Ch3m	-1.82
Ch3y	-48.08
Ch5y	-53.04
Ch6m	-17.87
Change	2.37%
Change From Open	2.37
Close	10.55
Days Gap	0
Depreciation Amortization	19,693,000
Dollar Volume	2,983,716
Earnings Date	2026-05-14
EBIT	TWD 29M
EBITDA	TWD 48.7M
EPS	TWD 0.31
F Score	5
FCF	TWD 19.8M
FCF EV Yield	1.81x
FCF Per Share	TWD 0.22
Financing CF	29,532,000
Fiscal Year End	December
Founded	1,989
Graham Number	4.67596
Graham Upside	-56.7
Income Tax	TWD -891,000
Investing CF	-48,248,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-06-30
Lynch Fair Value	TWD 2.92
Lynch Upside	-72.95
Ma150	11.77
Ma150ch	-8.27%
Ma20	11.11
Ma20ch	-2.79%
Net CF	34,414,000
Next Earnings Date	2026-05-14
Open	10.55
P FCF Ratio	48.94
P OCF Ratio	18.21
Position In Range	58.33
Ppne	231,099,000
Price Date	2026-05-08
Price EBITDA	TWD 19.88
Ptbv Ratio	3.4
Relative Volume	0.79x
Revenue	364,790,000x
Tax By Revenue	-0.24x
Tr6m	-17.87%
Volume	276,270

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4186 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4186 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4186?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+11.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.1%

Negative means the company is buying back shares.

Technical

TPEX/4186 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.2

Neutral momentum band

Price vs 200-day MA

-7.7%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

-0.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4186

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4186 stock rating?

tpex/4186 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4186 analysis?

The full report lives at /stocks/tpex/4186/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4186?

The latest report frames tpex/4186 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4186 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.